Statements (46)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antibiotic
|
| gptkbp:approves |
adults
children over 1 year |
| gptkbp:brand |
gptkb:Vigamox
gptkb:Avelox Moxeza |
| gptkbp:chemicalFormula |
C21H24FN3O4
|
| gptkbp:class |
fluoroquinolone
|
| gptkbp:clinicalTrials |
yes
|
| gptkbp:contraindication |
gptkb:myasthenia_gravis
tendon rupture |
| gptkbp:gestationPeriod |
C
|
| gptkbp:hasActivities |
broad spectrum
|
| https://www.w3.org/2000/01/rdf-schema#label |
moxifloxacin
|
| gptkbp:impact |
sinusitis
pneumonia pelvic inflammatory disease skin infections conjunctivitis urinary tract infections bacterial endocarditis bacterial keratitis chronic bronchitis exacerbations intra-abdominal infections |
| gptkbp:interactsWith |
antacids
iron supplements warfarin |
| gptkbp:isATypeOf |
218000-47-4
|
| gptkbp:issuedBy |
oral tablet
intravenous injection |
| gptkbp:notableFeature |
gptkb:Vigamox
gptkb:Avelox Moxeza |
| gptkbp:numberOfStudents |
12 hours
|
| gptkbp:nutritionalValue |
liver
|
| gptkbp:operates_in |
J01MA14
|
| gptkbp:patentMaintenanceFee |
1999
|
| gptkbp:route |
topical
ophthalmic |
| gptkbp:sideEffect |
dizziness
headache nausea diarrhea |
| gptkbp:triggerType |
inhibits bacterial DNA gyrase
|
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:waterManagement |
urine
|